Contrast media: Are there differences in nephrotoxicity among contrast media?

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Solomon, Richard ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ACUTE KIDNEY FAILURE; DRUG EFFECT; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY; OSMOLARITY; PATHOLOGY; RADIOGRAPHY; REVIEW;

ACUTE KIDNEY INJURY; CONTRAST MEDIA; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; OSMOLAR CONCENTRATION;

EID: 84893749022     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/934947     Document Type: Review

References (32)

1. Go A., Mozaffarian D., Roger V. L., Benjamin E. J., Gerry J. D., Borden W. B., Bravata D. M., Dai S., Ford E. S., Fox C. S., Franco S., Fullerton H. J., Gillespie C., Hailpern S. M., Heit J. A., Howard V. J., Huffman M. D., Kissela B. M., Kittner S. J., Lackland D. R., Lichtman J. H., Lisabeth L. D., Magid D., Marcus G. M., Marelli A., Matchar D. B., McGuire D. K., Mohler E. R., Moy C. S., Mussolino M. E., Nichol G., Paynter N. P., Schreiner P. J., Sorlie P. D., Stein J., Turan T. N., Virani S. S., Wong N. D., Woo D., Turner M. B., Heart disease and stroke statistics-2013 update: report from the American Heart Association. Circulation 2013 203 127 e6 e245
2. McCullough P. A., Wolyn R., Rocher L. L., Levin R. N., O'Neill W. W., Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. American Journal of Medicine 1997 103 5 368 375 2-s2.0-0030661687 10.1016/S0002-9343(97)00150-2 (Pubitemid 27506242)
3. Heyman S. N., Rosen S., Khamaisi M., Idée J., Rosenberger C., Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Investigative Radiology 2010 45 4 188 195 2-s2.0-77949867992 10.1097/RLI.0b013e3181d2eed8
4. Jost G., Lengsfeld P., Lenhard D. C., Pietsch H., Hütter J., Sieber M. A., Viscosity of iodinated contrast agents during renal excretion. European Journal of Radiology 2011 80 2 373 377 2-s2.0-80053619710 10.1016/j.ejrad.2011. 02.003
5. Ueda J., Furukawa T., Higashino K., Takahashi S., Araki Y., Kubo K., Nakashima T., Urine viscosity after injections of iotrolan or iomeprol. Acta Radiologica 1997 38 6 1079 1082 2-s2.0-0031279344 (Pubitemid 127452216)
6. Herrera J., Rodríguez-Iturbe B., Stimulation of tubular secretion of creatinine in health and in conditions associated with reduced nephron mass. Evidence for a tubular functional reserve. Nephrology Dialysis Transplantation 1998 13 3 623 629 2-s2.0-0031933805 10.1093/ndt/13.3.623 (Pubitemid 28119042)
7. Waikar S. S., Bonventre J. V., Creatinine kinetics and the definition of acute kidney injury. Journal of the American Society of Nephrology 2009 20 3 672 679 2-s2.0-62149133455 10.1681/ASN.2008070669
8. Murray P., Mehta R. L., Shaw A., Ronco C., Endre Z., Kellum J. A., Chawla L. S., Cruz D., Ince C., Okusa M. D., For the ADQI 10 workgroup. Current use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney International 2013 10.1038/ki.2013.374
9. Barrett B. J., Carlisle E. J., Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993 188 1 171 178 2-s2.0-0027301087 (Pubitemid 23183119)
10. Aspelin P., Aubry P., Fransson S., Strasser R., Willenbrock R., Berg K. J., Nephrotoxic effects in high-risk patients undergoing angiography. New England Journal of Medicine 2003 348 6 491 499 2-s2.0-0037421597 10.1056/NEJMoa021833 (Pubitemid 36159884)
11. From A., Al Badarin F. J., McDonald F. S., Bartholmai B. J., Cha S. S., Rihal C. S., Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy meta-analysis of randomized, controlled trials. Circulation 2010 3 4 351 358 2-s2.0-78650092846 10.1161/CIRCINTERVENTIONS.109. 917070
12. Heinrich M. C., Häberle L., Müller V., Bautz W., Uder M., Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 2009 250 1 68 86 2-s2.0-58149331038 10.1148/radiol.2501080833
13. McCullough P., Brown J. R., Effects of intra-arterial and intravenous iso-osmolar contrast medium (iodixanol) on the risk of contrast-induced acute kidney injury: a meta-analysis. Cardiorenal Medicine 2011 1 4 220 234 10.1159/000332384
14. Reed M., Meier P., Tamhane U. U., Welch K. B., Moscucci M., Gurm H. S., The relative renal safety of iodixanol compared with low-osmolar contrast media. A meta-analysis of randomized controlled trials. Journal of the American College of Cardiology 2009 2 7 645 654 2-s2.0-67650709416 10.1016/j.jcin.2009. 05.002
15. Wright R. S., Anderson J. L., Adams C. D., Bridges C. R., Casey D. E. Jr., Ettinger S. M., Fesmire F. M., Ganiats T. G., Jneid H., Lincoff A. M., Peterson E. D., Philippides G. J., Theroux P., Wenger N. K., Zidar J. P., Anderson J. L., Adams C. D., Antman E. M., Bridges C. R., Califf R. M., Casey D. E. Jr., Chavey 2nd. W. E., Fesmire F. M., Hochman J. S., Levin T. N., Lincoff A. M., Peterson E. D., Theroux P., Wenger N. K., Wright R. S., 2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular. Journal of the American College of Cardiology 2011 57 19 1920 1959 2-s2.0-79960065486
16. Solomon R. J., Mehran R., Natarajan M. K., Doucet S., Katholi R. E., Staniloae C. S., Sharma S. K., Labinaz M., Gelormini J. L., Barrett B. J., Contrast-induced nephropathy and long-term adverse events: cause and effect? Clinical Journal of the American Society of Nephrology 2009 4 7 1162 1169 2-s2.0-66149188637 10.2215/CJN.00550109
17. Katzberg R. W., Monsky W. L., Prionas N. D., Sidhar V., Southard J., Carlson J., Boone J. M., Lin T. C., Li C. S., Persistent CT nephrograms following cardiac catheterization and intervention: initial observations. Insights Imaging 2012 3 1 49 60 10.1007/s13244-011-0131-2
18. Jost G., Pietsch H., Sommer J., Sandner P., Lengsfeld P., Seidensticker P., Lehr S., Hütter J., Sieber M. A., Retention of iodine and expression of biomarkers for renal damage in the kidney after application of iodinated contrast media in rats. Investigative Radiology 2009 44 2 114 123 2-s2.0-66149130242 10.1097/RLI.0b013e318190fbd2
19. Li J., Solomon R. J., Creatinine increases after intravenous contrast administration: incidence and impact. Investigative Radiology 2010 45 8 471 476 2-s2.0-77954757961 10.1097/RLI.0b013e3181dc3b67
20. McDonald R., McDonald J. S., Bida J. P., Carter R. E., Fleming C. J., Misra S., Williamson E. E., Kallmes D. F., Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology 2013 267 1 106 118 10.1148/radiol.12121823
21. Davenport M., Khalatbari S., Dillman J. R., Cohan R. H., Caoili E. M., Ellis J. H., Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material. Radiology 2013 267 1 94 105 10.1148/radiol.12121394
22. Rao Q. A., Newhouse J. H., Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology 2006 239 2 392 397 2-s2.0-33646131852 10.1148/radiol.2392050413
23. Kooiman J., Van de Peppel W. R., Sijpkens Y. W. J., Brulez H., De Vries J. P. P. M., Nicolaie M. A., Putter H., Huisman M. V., Van der Kooij S. W., van Kooten C., Rabelink T. J., No increase in kidney injury molecule-1 and neutrophil-gelatinase associated lipocalin excretion following intravenous contrast enhanced CT. Journal of the American Society of Nephrology 2013
24. Bellemain-Appaix A., Beygui F., Lesty C., Gupta S., Silvain J., Le Feuvre C., Cayla G., Allali Y., Montalescot G., Collet J., Impact of anticoagulation on ionic and nonionic contrast media effect on thrombogenesis and fibrinolysis: the PEPCIT study. Catheterization and Cardiovascular Interventions 2012 79 5 823 833 2-s2.0-84859442414 10.1002/ccd.23080
25. Le Feuvre C., Batisse A., Collet J. P., Batisse J. P., Choussat R., Beygui F., Helft G., Montalescot G., Metzger J. P., Cardiac events after low osmolar ionic or isosmolar nonlonic contrast media utilization in the current era of coronary angioplasty. Catheterization and Cardiovascular Interventions 2006 67 6 852 858 2-s2.0-33744808991 10.1002/ccd.20670 (Pubitemid 43837067)
26. Scheller B., Hennen B., Pohl A., Schieffer H., Markwirth T., Acute and subacute stent occlusion: risk-reduction by ionic contrast media. European Heart Journal 2001 22 5 385 391 2-s2.0-0034937948 10.1053/euhj.2000.2319 (Pubitemid 32622443)
27. Bertrand M. E., Esplugas E., Piessens J., Rasch W., Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: a multicenter, randomized, double-blind study. Circulation 2000 101 2 131 136 2-s2.0-0033977684 (Pubitemid 30044250)
28. Davidson C., Laskey W. K., Hermiller J. B., Harrison J. K., Matthai W. Jr., Vlietstra R. E., Brinker J. A., Kereiakes D. J., Muhlestein J. B., Lansky A., Popma J. J., Buchbinder M., Hirshfeld J. W. Jr., Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial. Circulation 2000 101 18 2172 2177 2-s2.0-0034625176 (Pubitemid 30253046)
29. Schräder R., Esch I., Ensslen R., Fach W. A., Merle H., Scherer D., Sievert H., Spies H. F., Zeplin H. E., A randomized trial comparing the impact of a nonionic (iomeprol) versus an ionic (ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty. Journal of the American College of Cardiology 1999 33 2 395 402 2-s2.0-0033081617 10.1016/S0735-1097(98)00600-7 (Pubitemid 29234201)
30. Sutton A., Ashton V. J., Campbell P. G., Price D. J. A., Hall J. A., De Belder M. A., A randomized prospective trial of ioxaglate 320 (Hexabrix) vs. Iodixanol 320 (Visipaque) in patients undergoing percutaneous coronary intervention. Catheterization and Cardiovascular Interventions 2002 57 3 346 352 2-s2.0-0036843357 10.1002/ccd.10326 (Pubitemid 35266273)
31. Coca S., Is it AKI or nonrecovery of renal function that is important for long-term outcomes? Clinical Journal of the American Society of Nephrology 2013 8 2 173 176 10.2215/CJN.12621212
32. Liss P., Persson P. B., Hansell P., Lagerqvist B., Higher Incidence of Renal Failure in 77, 848 Patients Undergoing Coronary Intervention in Swedish Hospital Using Iso-Osmolar Contrast Media Compared to Low-Osmolar Contrast Media 2006 Vienna, Austria European Congress of Radiology